AGL Energy Limited (AGL) today reported its financial results for the six months ending 31 December 2024 (1H25). Key Financial Highlights: Updated FY25 Guidance: CEO Commentary on 1H25 Performance: AGL’s…
Mayne Pharma Reports Strong Revenue and Earnings Growth for 1H FY25
Mayne Pharma Group Limited (ASX: MYX) has provided a market update for the six months ending 31 December 2024 (1H FY25), reporting double-digit revenue growth and a significant improvement in…
Rhythm Biosciences Nears Completion of geneType™ Integration
Rhythm Biosciences Ltd (ASX: RHY) has successfully completed a significant portion of the geneType™ integration following its acquisition on December 24, 2024. This milestone marks a major step in restoring…
Perpetual Reports Mixed Q2 FY25 Performance Amid Currency Tailwinds
Key Highlights (Q2 FY25): Asset Management: Currency Boost Offsets Market & Outflows Despite facing net outflows of A$3.8 billion and negative market movements of A$4.1 billion, Perpetual’s AUM increased to…
EBR Systems Expands Manufacturing with New Facility Lease
Key Highlights Details of the Expansion CEO CommentaryJohn McCutcheon, President & CEO, stated: “This facility is a pivotal step in transitioning EBR into a commercial medical device company addressing significant…
KMD Brands Limited (NZX/ASX: KMD): Trading Update for FY25
KMD Brands reports improving sales trends, particularly in the direct-to-consumer (DTC) channel, for the first five months of FY25. Key highlights (unaudited) for the period ending December 2024 include: Performance…
NOVONIX Announces CEO Transition as Company Prepares for Next Growth Phase
NOVONIX Limited (NASDAQ: NVX, ASX: NVX), a leader in battery materials and technology, has announced the planned transition of its Chief Executive Officer (CEO). Dr. Chris Burns will step down…
Beach Energy FY25 Second Quarter Activities Report
FY25 Q2 Key Highlights: Production & Revenue: Operational Achievements: Financial Performance: Production Overview: Projects Update: Otway Basin: Waitsia Gas Plant (Perth Basin): Moomba CCS: Key Financial Metrics: Metric Q2 FY25…
Resmed (RMD): A Strong Buy with 30% Upside
Goldman Sachs has initiated coverage on Resmed (RMD) with a “Buy” rating and a 12-month price target of A$48.90, implying a 30% upside. The positive outlook is driven by several…
DigiCo REIT (DGT.AX): A Strong Buy with 30% Upside: Goldman
DigiCo REIT (DGT.AX), a newly established globally diversified data centre owner, operator, and developer, has caught the attention of investors with its unique growth prospects and compelling valuation. The company…